These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 27774826
1. Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy. Hamza AH, Al-Bishri WM, Damiati LA, Ahmed HH. Ren Fail; 2017 Nov; 39(1):67-76. PubMed ID: 27774826 [Abstract] [Full Text] [Related]
2. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment. Li Y, Liu J, Liao G, Zhang J, Chen Y, Li L, Li L, Liu F, Chen B, Guo G, Wang C, Yang L, Cheng J, Lu Y. Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379 [Abstract] [Full Text] [Related]
3. Bone-marrow mesenchymal stem cell transplantation to treat diabetic nephropathy in tree shrews. Pan XH, Yang XY, Yao X, Sun XM, Zhu L, Wang JX, Pang RQ, Cai XM, Dai JJ, Ruan GP. Cell Biochem Funct; 2014 Jul; 32(5):453-63. PubMed ID: 24867093 [Abstract] [Full Text] [Related]
4. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress. Lv S, Cheng J, Sun A, Li J, Wang W, Guan G, Liu G, Su M. Diabetes Res Clin Pract; 2014 Apr; 104(1):143-54. PubMed ID: 24513119 [Abstract] [Full Text] [Related]
5. Kidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy rats. Zhang Y, Ye C, Wang G, Gao Y, Tan K, Zhuo Z, Liu Z, Xia H, Yang D, Li P. Biomed Res Int; 2013 Apr; 2013():526367. PubMed ID: 23762850 [Abstract] [Full Text] [Related]
6. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats. Zhou H, Tian HM, Long Y, Zhang XX, Zhong L, Deng L, Chen XH, Li XQ. Chin Med J (Engl); 2009 Nov 05; 122(21):2573-9. PubMed ID: 19951572 [Abstract] [Full Text] [Related]
7. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration. Lv SS, Liu G, Wang JP, Wang WW, Cheng J, Sun AL, Liu HY, Nie HB, Su MR, Guan GJ. Int Immunopharmacol; 2013 Oct 05; 17(2):275-82. PubMed ID: 23791972 [Abstract] [Full Text] [Related]
8. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. Kubota K, Nakano M, Kobayashi E, Mizue Y, Chikenji T, Otani M, Nagaishi K, Fujimiya M. PLoS One; 2018 Oct 05; 13(9):e0204252. PubMed ID: 30240403 [Abstract] [Full Text] [Related]
9. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines. Bai Y, Wang J, He Z, Yang M, Li L, Jiang H. Med Sci Monit; 2019 Apr 26; 25():3069-3076. PubMed ID: 31023998 [Abstract] [Full Text] [Related]
10. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats. Zhang MH, Feng L, Zhu MM, Gu JF, Jiang J, Cheng XD, Ding SM, Wu C, Jia XB. J Ethnopharmacol; 2014 Apr 26; 151(1):591-600. PubMed ID: 24269777 [Abstract] [Full Text] [Related]
11. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products. Liu K, Xu H, Lv G, Liu B, Lee MK, Lu C, Lv X, Wu Y. Life Sci; 2015 Feb 15; 123():78-85. PubMed ID: 25623853 [Abstract] [Full Text] [Related]
12. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein. Mohammad Dezashibi H, Farzad-Mohajeri S, Bandehpour M, Shabani A, Kazemi B. Cell Biochem Funct; 2023 Dec 15; 41(8):1412-1421. PubMed ID: 37877623 [Abstract] [Full Text] [Related]
14. Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy. Elseweidy MM, Elswefy SE, Younis NN, Zaghloul MS. Exp Biol Med (Maywood); 2013 Aug 01; 238(8):881-8. PubMed ID: 23970406 [Abstract] [Full Text] [Related]